↓ Skip to main content

Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study

Overview of attention for article published in Targeted Oncology, September 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
18 Mendeley
Title
Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study
Published in
Targeted Oncology, September 2019
DOI 10.1007/s11523-019-00672-2
Pubmed ID
Authors

Jwa Hoon Kim, Sun Young Kim, Kyu-pyo Kim, Tae Won Kim, Sun Young Chae, Hwa Jung Kim, Jae Seung Kim, Jin-Sook Ryu, Dae Hyuk Moon, Jeong Eun Kim, Yong Sang Hong

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 11%
Professor > Associate Professor 2 11%
Lecturer 1 6%
Student > Bachelor 1 6%
Student > Master 1 6%
Other 3 17%
Unknown 8 44%
Readers by discipline Count As %
Medicine and Dentistry 5 28%
Nursing and Health Professions 2 11%
Psychology 2 11%
Business, Management and Accounting 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2019.
All research outputs
#18,694,159
of 23,168,000 outputs
Outputs from Targeted Oncology
#396
of 557 outputs
Outputs of similar age
#258,442
of 345,857 outputs
Outputs of similar age from Targeted Oncology
#14
of 19 outputs
Altmetric has tracked 23,168,000 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 557 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,857 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.